Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission

por Curtis, Jeffrey R., Emery, Paul, Karis, Elaine, Haraoui, Boulos, Bykerk, Vivian, Yen, Priscilla K., Kricorian, Greg, Chung, James B.
Publicado 2021

Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis: Results From the SEAM-RA Trial

por Curtis, Jeffrey R., Stolshek, Bradley, Emery, Paul, Haraoui, Boulos, Karis, Elaine, Kricorian, Greg, Collier, David H., Yen, Priscilla K., Bykerk, Vivian P.
Publicado 2023

Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid–Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial)

por Grenon, S Marlene, Owens, Christopher D, Nosova, Emily V, Hughes-Fulford, Millie, Alley, Hugh F, Chong, Karen, Perez, Sandra, Yen, Priscilla K, Boscardin, John, Hellmann, Jason, Spite, Matthew, Conte, Michael S
Publicado 2015

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis

por Coates, Laura C, Merola, Joseph F, Mease, Philip J, Ogdie, Alexis, Gladman, Dafna D, Strand, Vibeke, van Mens, Leonieke J J, Liu, Lyrica, Yen, Priscilla K, Collier, David H, Kricorian, Gregory, Chung, James B, Helliwell, Philip S
Publicado 2020